https://doi.org/10.4081/reumatismo.2017.923

First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome

Vol. 69 No. 2 (2017)
Submitted: 10 September 2016
Accepted: 27 April 2017
Published: 3 August 2017
Myelodisplastic syndrome, Myositis specific autoantibodies, Anti-TIF1γ, Dermatomyositis.
Abstract Views: 1348
PDF: 801
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

B. Palterer
Experimental and Clinical Medicine Dept., University of Florence, Florence, Italy.
G. Vitiello
gianfranco.vitiello@unifi.it
Experimental and Clinical Medicine Dept., University of Florence, Florence, Italy.
D. Cammelli
Rheumatology Section/Immunoallergology Unit, AOU-Careggi, Florence, Italy.
Inflammatory myopathies as para-neoplastic phenomena were first described by Sterz in 1916. Recently, myositis specific autoantibodies were described in cancer-associated myositis. Anti-transcription intermediary factor 1 gamma (anti-TIF1γ) antibodies have been found in both young adults affected by juvenile dermatomyositis and in elderly patients with cancer-associated myositis. In this regard, we report herein the first case of anti-TIF1γ dermatomyositis secondary to a myelodysplastic syndrome.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

-
B. Palterer, Experimental and Clinical Medicine Dept., University of Florence, Florence
Resident in Allergy and Clinical Immunology
G. Vitiello, Experimental and Clinical Medicine Dept., University of Florence, Florence
Resident in Allergy and Clinical Immunology
D. Cammelli, Rheumatology Section/Immunoallergology Unit, AOU-Careggi, Florence
Head of the Reumatology Section of the Immunoallergology Unit

How to Cite

Palterer, B., Vitiello, G., & Cammelli, D. (2017). First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome. Reumatismo, 69(2), 75–77. https://doi.org/10.4081/reumatismo.2017.923

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Similar Articles

<< < 3 4 5 6 7 8 9 10 11 12 > >> 

You may also start an advanced similarity search for this article.